Literature DB >> 9951692

Platelet dysfunction as the presenting feature of atypical myelodysplastic syndrome with monosomy 7, normal blood counts and no bleeding tendency.

D Marisavljević1, P Antunović, P Miljić, M Pantić.   

Abstract

A 71-year-old male patient with atypical myelodysplastic syndrome showing monosomy 7 is described. He presented with severe foot pains, trophic skin and nail changes, loss of distal pulses, all compatible with peripheral arterial occlusive disease. He had completely normal blood counts and no bleeding tendency. Prolonged bleeding time was disclosed by chance, during routine haemostatic studies. An acquired platelet dysfunction was considered, with prolonged bleeding time and large platelets that failed to aggregate in response to arachidonic acid and that had impaired response to collagen and adrenaline. The bone marrow was hypercellular, with numerous dysplastic megakaryocytes and two other slightly dysplastic myeloid lines. Cytogenetic analyses of the bone marrow cells showed a mosaic karyotype: 46,XY/45,XY,-7. On angiography, bilateral thrombosis of the iliac, superficial femoral and popliteal was disclosed. The patient was prepared with platelet transfusions. Arterial thrombectomy and amputation of the left calf were performed. Ten months later, his blood counts showed mild pancytopenia. He died at home. The authors discuss some clinical and pathogenetical aspects of such presentations of myelodysplastic syndromes.

Entities:  

Mesh:

Year:  1998        PMID: 9951692     DOI: 10.1007/BF02787212

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  12 in total

Review 1.  Platelet function in the myelodysplastic syndromes.

Authors:  V Rasi; R Lintula
Journal:  Scand J Haematol Suppl       Date:  1986

Review 2.  The myelodysplastic syndrome--a practical guide.

Authors:  T J Hamblin; D G Oscier
Journal:  Hematol Oncol       Date:  1987 Jan-Mar       Impact factor: 5.271

3.  An acquired Bernard-Soulier-like platelet defect associated with juvenile myelodysplastic syndrome.

Authors:  M C Berndt; A Kabral; P Grimsley; N Watson; T I Robertson; K F Bradstock
Journal:  Br J Haematol       Date:  1988-01       Impact factor: 6.998

4.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

5.  Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity.

Authors:  N H Russell; J P Keenan; A J Bellingham
Journal:  Br J Haematol       Date:  1979-03       Impact factor: 6.998

6.  The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification.

Authors:  S J May; S A Smith; A Jacobs; A Williams; R Bailey-Wood
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

Review 7.  Platelet function defects associated with hemorrhage or thrombosis.

Authors:  R L Bick
Journal:  Med Clin North Am       Date:  1994-05       Impact factor: 5.456

8.  Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.

Authors:  T W Malpass; B Savage; S R Hanson; S J Slichter; L A Harker
Journal:  J Lab Clin Med       Date:  1984-06

9.  Platelet function in preleukaemia.

Authors:  R Lintula; V Rasi; E Ikkala; G H Borgström; P Vuopio
Journal:  Scand J Haematol       Date:  1981-01

10.  Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis.

Authors:  B K Raman; E J Van Slyck; J Riddle; M A Sawdyk; J P Abraham; S M Saeed
Journal:  Am J Clin Pathol       Date:  1989-06       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.